Table 2 CK7/20 phenotype and CDX2 expression in our studied groups
| Â | Colorectal AdenoCa (n = 118) | Gastric AdenoCa (n = 59) | Pancreatic AdenoCa (n = 32) | |||
|---|---|---|---|---|---|---|
| Â | CDX2+ | CDX2- | CDX2+ | CDX2- | CDX2+ | CDX2- |
CK7-/CK20+ | 74 (62%) | 1 (1%) | 3 (5%) | 0 (0%) | 0 (0%) | 0 (0%) |
CK7+/CK20+ | 22 (19%) | 2 (2%) | 21 (36%) | 7 (12%) | 2 (6%) | 5 (16%) |
CK7+/CK20- | 2 (2%) | 0 (0%) | 8 (14%) | 11 (19%) | 3 (9%) | 21 (66%) |
CK7-/CK20- | 16 (14%) | 1 (1%) | 4 (7%) | 5 (9%) | 0 (0%) | 1 (3%) |